WHO ICTRP trial
Comparison of two intravenous methylprednisolone regimens for patients with…
ChiCTR-IPR-15006848 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-IPR-15006848 |
|---|---|
| Public title | Comparison of two intravenous methylprednisolone regimens for patients with moderate to severe and active Graves’ ophthalmopathy |
| Scientific title | Comparison of two intravenous methylprednisolone regimens for patients with moderate to severe and active Graves’ ophthalmopathy |
| Primary sponsor | Department of Endocrinology and Metabolism, the Affiliated Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | Post-market |
| Conditions | Graves' ophthalmopathy |
| Interventions | Two groups:Two doses of MP monthly for 3 months |
| Registration date | Jul 31, 2015 |
| Target size | Two groups:40 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: